鳥居薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/07/20 | 3,355 | 3,385 | 3,335 | 3,370 | +70 | +2.1% | 58,900 |
| 2022/07/19 | 3,300 | 3,310 | 3,240 | 3,300 | ±0 | ±0% | 62,000 |
| 2022/07/15 | 3,370 | 3,370 | 3,290 | 3,300 | -50 | -1.5% | 40,700 |
| 2022/07/14 | 3,340 | 3,360 | 3,315 | 3,350 | -15 | -0.4% | 48,300 |
| 2022/07/13 | 3,365 | 3,395 | 3,345 | 3,365 | -45 | -1.3% | 61,600 |
| 2022/07/12 | 3,390 | 3,420 | 3,375 | 3,410 | +5 | +0.1% | 34,800 |
| 2022/07/11 | 3,330 | 3,410 | 3,330 | 3,405 | +130 | +4% | 86,500 |
| 2022/07/08 | 3,265 | 3,320 | 3,215 | 3,275 | -15 | -0.5% | 90,100 |
| 2022/07/07 | 3,305 | 3,340 | 3,280 | 3,290 | +15 | +0.5% | 64,800 |
| 2022/07/06 | 3,225 | 3,275 | 3,220 | 3,275 | +50 | +1.6% | 52,800 |
| 2022/07/05 | 3,200 | 3,225 | 3,175 | 3,225 | +25 | +0.8% | 33,100 |
| 2022/07/04 | 3,230 | 3,270 | 3,195 | 3,200 | +40 | +1.3% | 49,700 |
| 2022/07/01 | 3,230 | 3,250 | 3,150 | 3,160 | -50 | -1.6% | 57,100 |
| 2022/06/30 | 3,260 | 3,290 | 3,190 | 3,210 | -55 | -1.7% | 90,600 |
| 2022/06/29 | 3,260 | 3,265 | 3,225 | 3,265 | -40 | -1.2% | 68,700 |
| 2022/06/28 | 3,240 | 3,310 | 3,195 | 3,305 | +60 | +1.8% | 90,500 |
| 2022/06/27 | 3,220 | 3,270 | 3,205 | 3,245 | +35 | +1.1% | 78,800 |
| 2022/06/24 | 3,140 | 3,210 | 3,125 | 3,210 | +65 | +2.1% | 82,100 |
| 2022/06/23 | 3,045 | 3,160 | 3,045 | 3,145 | +145 | +4.8% | 96,200 |
| 2022/06/22 | 2,970 | 3,030 | 2,970 | 3,000 | +37 | +1.2% | 36,700 |
| 2022/06/21 | 2,945 | 2,983 | 2,931 | 2,963 | +40 | +1.4% | 51,800 |
| 2022/06/20 | 2,842 | 2,930 | 2,842 | 2,923 | +31 | +1.1% | 40,100 |
| 2022/06/17 | 2,852 | 2,912 | 2,835 | 2,892 | -22 | -0.8% | 96,200 |
| 2022/06/16 | 2,854 | 2,928 | 2,854 | 2,914 | +60 | +2.1% | 54,000 |
| 2022/06/15 | 2,894 | 2,894 | 2,854 | 2,854 | -40 | -1.4% | 32,600 |
| 2022/06/14 | 2,908 | 2,920 | 2,876 | 2,894 | -38 | -1.3% | 46,600 |
| 2022/06/13 | 2,929 | 2,949 | 2,918 | 2,932 | -12 | -0.4% | 21,400 |
| 2022/06/10 | 2,974 | 2,974 | 2,936 | 2,944 | -34 | -1.1% | 42,500 |
| 2022/06/09 | 3,000 | 3,020 | 2,973 | 2,978 | -22 | -0.7% | 31,000 |
| 2022/06/08 | 2,942 | 3,005 | 2,930 | 3,000 | +50 | +1.7% | 42,900 |
| 2022/06/07 | 2,981 | 2,992 | 2,946 | 2,950 | -40 | -1.3% | 25,800 |
| 2022/06/06 | 2,980 | 3,010 | 2,976 | 2,990 | -3 | -0.1% | 19,800 |
| 2022/06/03 | 2,991 | 3,020 | 2,973 | 2,993 | -4 | -0.1% | 30,900 |
| 2022/06/02 | 3,020 | 3,020 | 2,995 | 2,997 | -33 | -1.1% | 21,800 |
| 2022/06/01 | 3,020 | 3,075 | 3,020 | 3,030 | +10 | +0.3% | 31,900 |
| 2022/05/31 | 3,045 | 3,065 | 3,010 | 3,020 | ±0 | ±0% | 72,600 |
| 2022/05/30 | 2,982 | 3,045 | 2,979 | 3,020 | +44 | +1.5% | 71,600 |
| 2022/05/27 | 2,959 | 2,998 | 2,959 | 2,976 | -3 | -0.1% | 39,400 |
| 2022/05/26 | 2,982 | 3,005 | 2,968 | 2,979 | -51 | -1.7% | 30,800 |
| 2022/05/25 | 3,040 | 3,065 | 3,020 | 3,030 | -20 | -0.7% | 33,800 |
| 2022/05/24 | 3,015 | 3,110 | 3,015 | 3,050 | +25 | +0.8% | 50,100 |
| 2022/05/23 | 3,000 | 3,060 | 2,989 | 3,025 | ±0 | ±0% | 32,300 |
| 2022/05/20 | 2,999 | 3,040 | 2,995 | 3,025 | +10 | +0.3% | 18,900 |
| 2022/05/19 | 2,932 | 3,040 | 2,932 | 3,015 | +23 | +0.8% | 45,100 |
| 2022/05/18 | 2,930 | 2,995 | 2,930 | 2,992 | +62 | +2.1% | 46,400 |
| 2022/05/17 | 2,920 | 2,994 | 2,880 | 2,930 | -22 | -0.7% | 64,200 |
| 2022/05/16 | 3,080 | 3,085 | 2,952 | 2,952 | -98 | -3.2% | 59,400 |
| 2022/05/13 | 3,055 | 3,075 | 3,015 | 3,050 | +5 | +0.2% | 49,500 |
| 2022/05/12 | 3,080 | 3,090 | 3,040 | 3,045 | -45 | -1.5% | 39,700 |
| 2022/05/11 | 3,130 | 3,145 | 3,060 | 3,090 | -25 | -0.8% | 30,200 |
701～
750
件表示中 / 3710件
類似銘柄と比較する
現在ご覧いただいている「鳥居薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| サワイＧＨＤ | 178,600円 | +5.9% | +24.5% | 3.08% | 11.85倍 | 1.12倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| キッセイ薬 | 429,000円 | +3.6% | +6.1% | 2.80% | 14.45倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.81倍 | 0.95倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| 東和薬品 | 305,500円 | +7.9% | -3.3% | 2.62% | 8.50倍 | 0.88倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
市場注目の銘柄
チャート関連のコラム
